Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPE | Q05469 | 2/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | TMEM97 | Q5BJF2 | 3/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.37 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.37 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12042819 | 0.94 | LIPE (0.39) | LIPEENPP2ADRB2TMEM97STAT3 | |
| SCHEMBL12042770 | 0.93 | TMEM97 (0.38) | LIPEEPHX2TMEM97 | |
| SCHEMBL13158283 | 0.93 | MCHR1 (0.39) | EPHX2TMEM97 | |
| SCHEMBL12042799 | 0.93 | DRD2 (0.41) | LIPEEPHX2TMEM97 | |
| SCHEMBL9984310 | 0.91 | TMEM97 (0.42) | LIPEEPHX2TMEM97 | |
| SCHEMBL12042816 | 0.91 | TMEM97 (0.42) | LIPEEPHX2TMEM97 | |
| SCHEMBL12042808 | 0.90 | TMEM97 (0.37) | LIPETMEM97 | |
| SCHEMBL12042811 | 0.90 | LMNA (0.40) | LIPEEPHX2TMEM97 | |
| SCHEMBL12059663 | 0.90 | LIPE (0.42) | LIPEENPP2ADRB2EPHX2STAT3 | |
| SCHEMBL15996851 | 0.89 | LIPE (0.43) | LIPEADRB2EPHX2P2RY14CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010115688-A1 | ANTHELMINTIC AGENTS AND THEIR USE | INTERVET INTERNATIONAL B.V. (NL) | 2010-10-14 | — | — | WO | disclosed |